Effect of early chemotherapy intensification with BEACOPP in high-tisk, interim-PET positive, advanced-stage Hodgkin lymphoma on overall treatment outcome of ABVD

被引：0
|
作者：
Fiore, F.
Patti, K.
Viviani, S.
Rossi, A.
Di Raimondo, F.
Cantonetti, M.
Feldman, T.
Biggi, A.
Barrington, S.
Gallamini, A.
机构：
[1] S Croce Mem Hosp, Dept Hematol, Cuneo, Italy
[2] V Cervello Hosp, Dept Hematol, Palermo, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[4] Osped Riuniti Bergamo, Dept Hematol, Bergamo, Italy
[5] Univ Catania, Dept Hematol, Catania, Italy
[6] Univ Roma Tor Vergata, Dept Hematol, Rome, Italy
[7] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[8] S Croce Gen Hosp, Dept Nucl Med, Cuneo, Italy
[9] Kings Coll London, PET Imaging Ctr St Thomas, Div Imaging, London WC2R 2LS, England
[10] S Croce Gen Hosp, Dept Hematol, Cuneo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy
    Savage, K. J.
    Connors, J. M.
    Klasa, R. J.
    Hoskins, P.
    Shenkier, T. N.
    Gascoyne, R. D.
    Bhimji, S.
    Pickles, T.
    Benard, F.
    Wilson, D.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 129 - 131
  • [43] High Risk Advanced Stage Hodgkin Lymphoma Is Well Controlled with 2 Cycles of Escalated Beacopp Followed By 4 Cycles of ABVD in Patients Who Rapidly Achieve Metabolic CR on Interim PET/CT Scan
    Kedmi, Meirav
    Apel, Arie
    Davidson, Tima
    Goshen, Elinor
    Davidovitz, Yaron
    Berkowicz, Miriam
    Levi, Itai
    Dann, Eldad J.
    Polliack, Aaron
    Nagler, Arnon
    Avigdor, Abraham
    BLOOD, 2014, 124 (21)
  • [44] Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study
    Borchmann, Peter
    Goergen, Helen
    Kobe, Carsten
    Lohri, Andreas
    Greil, Richard
    Eichenauer, Dennis A.
    Zijlstra, Josee M.
    Markova, Jana
    Meissner, Julia
    Feuring-Buske, Michaela
    Huttmann, Andreas
    Dierlamm, Judith
    Sokler, Martin
    Krause, Stefan W.
    Eich, Hans
    Baues, Christian
    Kreissl, Stefanie
    Fuchs, Michael
    Dietlein, Markus
    Engert, Andreas
    BLOOD, 2017, 130
  • [45] RAPID Trial Demonstrates Low Positive Predictive Value of Interim FDG-PET in Early-stage Hodgkin Lymphoma After Three Cycles of ABVD
    Fulbright, Joy M.
    Williams, Sarah E.
    Pahud, Barbara A.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 165 - 165
  • [46] FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Plutschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1270 - 1274
  • [47] Addition of Rituximab to BEACOPPescalated to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study.
    Borchmann, Peter
    Haverkamp, Heinz
    Lohri, Andreas
    Kreissl, Stefanie
    Greil, Richard
    Markova, Jana
    Feuring-Buske, Michaela
    Meissner, Julia
    Duehrsen, Ulrich
    Engel, Nicole
    Keller, Ulrich
    Maschmeyer, Georg
    Dietlein, Markus
    Kobe, Carsten
    Fuchs, Michael
    Diehl, Volker
    Engert, Andreas
    BLOOD, 2014, 124 (21)
  • [48] Patterns of PET positive residual tissue at early interim staging and risk of treatment failure in advanced-stage Hodgkin's Lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group
    Ferdinandus, J.
    van Heek, L.
    Roth, K. S.
    Dietlein, M.
    Eich, H.
    Baues, C.
    Borchmann, P.
    Kobe, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S47 - S47
  • [49] Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles
    Dlugosz-Danecka, Monika
    Szmit, Sebastian
    Kocurek, Anna
    Kozlik, Pawel
    Giza, Agnieszka
    Zimowska-Curylo, Dagmara
    Malkowski, Bogdan
    Sowa-Staszczak, Anna
    Kuzdzal, Jaroslaw
    Jurczak, Wojciech
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (04): : 259 - 266
  • [50] EARLY INTERIM FDG-PET IN ADVANCED-STAGE HODGKIN LYMPHOMA (HL). LONG-TERM RESULTS OF THE ITALIAN-DANISH COOPERATIVE STUDY
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Pregno, P.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Torchio, P.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 191 - 191
12345